These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
649 related articles for article (PubMed ID: 34177896)
1. Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies. Gando S; Wada T Front Immunol; 2021; 12():649122. PubMed ID: 34177896 [TBL] [Abstract][Full Text] [Related]
2. Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key? Meini S; Zanichelli A; Sbrojavacca R; Iuri F; Roberts AT; Suffritti C; Tascini C Front Immunol; 2020; 11():2014. PubMed ID: 32849666 [TBL] [Abstract][Full Text] [Related]
3. NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond. Zhu Y; Chen X; Liu X Front Immunol; 2022; 13():838011. PubMed ID: 35309344 [TBL] [Abstract][Full Text] [Related]
4. Trauma-induced innate immune activation and disseminated intravascular coagulation. Gando S; Levi M; Toh CH J Thromb Haemost; 2024 Feb; 22(2):337-351. PubMed ID: 37816463 [TBL] [Abstract][Full Text] [Related]
5. The therapeutic relevance of the Kallikrein-Kinin axis in SARS-cov-2-induced vascular pathology. Sohaei D; Hollenberg M; Janket SJ; Diamandis EP; Poda G; Prassas I Crit Rev Clin Lab Sci; 2023 Jan; 60(1):25-40. PubMed ID: 35930434 [TBL] [Abstract][Full Text] [Related]
6. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra). Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052 [TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Spike Proteins and Cell-Cell Communication Inhibits TFPI and Induces Thrombogenic Factors in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for COVID-19 Coagulopathy Pathogenesis. Bhargavan B; Kanmogne GD Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142345 [TBL] [Abstract][Full Text] [Related]
8. Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights From Thrombosis and Hemostasis. Gando S; Wada T Shock; 2022 Jan; 57(1):1-6. PubMed ID: 34172612 [TBL] [Abstract][Full Text] [Related]
9. Characterization of Unique Pathological Features of COVID-Associated Coagulopathy: Studies with AC70 hACE2 Transgenic Mice Highly Permissive to SARS-CoV-2 Infection. Drelich AK; Rayavara K; Hsu J; Saenkham-Huntsinger P; Judy BM; Tat V; Ksiazek TG; Peng BH; Tseng CK PLoS Pathog; 2024 Jun; 20(6):e1011777. PubMed ID: 38913740 [TBL] [Abstract][Full Text] [Related]
10. [Age-dependent possible role of contact-activated blood coagulation factor XII as a potential contributor to the “bradykinin storm” in COVID-19 patients]. Sipka S; Tóth A; Sipka S Orv Hetil; 2020 Dec; 161(50):2099-2103. PubMed ID: 33310922 [TBL] [Abstract][Full Text] [Related]
11. The Cross-Talk between Thrombosis and Inflammatory Storm in Acute and Long-COVID-19: Therapeutic Targets and Clinical Cases. Acanfora D; Acanfora C; Ciccone MM; Scicchitano P; Bortone AS; Uguccioni M; Casucci G Viruses; 2021 Sep; 13(10):. PubMed ID: 34696334 [TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 infection results in upregulation of Plasminogen Activator Inhibitor-1 and Neuroserpin in the lungs, and an increase in fibrinolysis inhibitors associated with disease severity. Toomer KH; Gerber GF; Zhang Y; Daou L; Tushek M; Hooper JE; Francischetti IMB EJHaem; 2023 May; 4(2):324-338. PubMed ID: 37206290 [TBL] [Abstract][Full Text] [Related]
13. Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination. Yamada S; Asakura H Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328761 [TBL] [Abstract][Full Text] [Related]
14. Complement activation and coagulopathy - an ominous duo in COVID19. Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807 [TBL] [Abstract][Full Text] [Related]
15. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses. Nascimento Conde J; Schutt WR; Gorbunova EE; Mackow ER mBio; 2020 Dec; 11(6):. PubMed ID: 33310781 [TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of vasculopathy and coagulopathy in COVID-19. Al-Gburi S; Beissert S; Günther C Biol Chem; 2021 Nov; 402(12):1505-1518. PubMed ID: 34657406 [TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Spike Proteins and Cell-Cell Communication Induce P-Selectin and Markers of Endothelial Injury, NETosis, and Inflammation in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for the Pathogenesis of COVID-19 Coagulopathy. Bhargavan B; Kanmogne GD Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628764 [TBL] [Abstract][Full Text] [Related]
18. CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation. Sung PS; Yang SP; Peng YC; Sun CP; Tao MH; Hsieh SL J Biomed Sci; 2022 Jul; 29(1):52. PubMed ID: 35820906 [TBL] [Abstract][Full Text] [Related]
19. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction. Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093 [TBL] [Abstract][Full Text] [Related]
20. Lung Epithelial Cell Transcriptional Regulation as a Factor in COVID-19-associated Coagulopathies. FitzGerald ES; Chen Y; Fitzgerald KA; Jamieson AM Am J Respir Cell Mol Biol; 2021 Jun; 64(6):687-697. PubMed ID: 33740387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]